secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2026-03-10T23:59:59+00:00
Accession:  0001156039-26-000024
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health reaffirms FY2026 adj. EPS at least $25.50, benefit expense ratio ~90.2%
--------------------------------------------------------------------------------

- Reaffirms adjusted shareholders' earnings for FY2026 at least $25.50 per diluted share.
- Reaffirms 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.
- Guidance includes impact of potential CMS sanctions suspending Medicare Advantage enrollment effective March 31, 2026 if not resolved.
- Company cannot provide GAAP reconciliation due to uncertainty over financial payments to resolve CMS matter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000024/0001156039-26-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000024/elv-20260310.htm
  HTML page:      https://secwatch.observer/filing/0001156039-26-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer